Assessing the degree of myelin injury in patients with multiple sclerosis (MS) is challenging due to the lack of magnetic resonance imaging (MRI) methods specific to myelin quantity. By measuring distinct tissue parameters from a two-pool model of the magnetization transfer (MT) effect, quantitative magnetization transfer (qMT) may yield these indices. However, due to long scan times, qMT has not been translated clinically.
Objectives:
We aim to assess the clinical feasibility of a recently optimized selective inversion recovery (SIR) qMT and to test the hypothesis that SIR-qMT-derived metrics are informative of radiological and clinical disease-related changes in MS.
Methods:
A total of 18 MS patients and 9 age- and sex-matched healthy controls (HCs) underwent a 3.0 Tesla (3 T) brain MRI, including clinical scans and an optimized SIR-qMT protocol. Four subjects were re-scanned at a 2-week interval to determine inter-scan variability.
Results:
SIR-qMT measures differed between lesional and non-lesional tissue (p < 0.0001) and between normal-appearing white matter (NAWM) of patients with more advanced disability and normal white matter (WM) of HCs (p < 0.05). SIR-qMT measures were associated with lesion volumes, disease duration, and disability scores (p ⩽ 0.002).
Conclusion:
SIR-qMT at 3 T is clinically feasible and predicts both radiological and clinical disease severity in MS.
MahadDHTrappBDLassmannH.Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol2015; 14(2): 183–193.
2.
FoxRJThompsonABakerD, et al. Setting a research agenda for progressive multiple sclerosis: the international collaborative on progressive MS. Mult Scler2012; 18(11): 1534–1540.
3.
WolffSDBalabanRS.Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med1989; 10(1): 135–144.
4.
LauleCVavasourIMKolindSH, et al. Magnetic resonance imaging of myelin. Neurotherapeutics2007; 4(3): 460–484.
5.
VavasourIMLauleCLiDK, et al. Is the magnetization transfer ratio a marker for myelin in multiple sclerosis. J Magn Reson Imaging2011; 33(3): 713–718.
6.
OdrobinaEELamTYPunT, et al. MR properties of excised neural tissue following experimentally induced demyelination. NMR Biomed2005; 18(5): 277–284.
7.
HenkelmanRMHuangXXiangQS, et al. Quantitative interpretation of magnetization transfer. Magn Reson Med1993; 29(6): 759–766.
8.
BerryIBarkerGJBarkhofF, et al. A multicenter measurement of magnetization transfer ratio in normal white matter. J Magn Reson Imaging1999; 9(3): 441–446.
9.
SchmiererKScaravilliFAltmannDR, et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol2004; 56(3): 407–415.
10.
MollNMRietschAMThomasS, et al. Multiple sclerosis normal-appearing white matter: pathology-imaging correlations. Ann Neurol2011; 70(5): 764–773.
11.
BlezerELBauerJBrokHP, et al. Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis. NMR Biomed2007; 20(2): 90–103.
12.
SledJGPikeGB.Quantitative interpretation of magnetization transfer in spoiled gradient echo MRI sequences. J Magn Reson2000; 145(1): 24–36.
13.
GochbergDFGoreJC.Quantitative imaging of magnetization transfer using an inversion recovery sequence. Magn Reson Med2003; 49(3): 501–505.
14.
LiKZuZXuJ, et al. Optimized inversion recovery sequences for quantitative T1 and magnetization transfer imaging. Magn Reson Med2010; 64(2): 491–500.
15.
SchmiererKTozerDJScaravilliF, et al. Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J Magn Reson Imaging2007; 26(1): 41–51.
16.
JanveVAZuZYaoSY, et al. The radial diffusivity and magnetization transfer pool size ratio are sensitive markers for demyelination in a rat model of type III multiple sclerosis (MS) lesions. Neuroimage2013; 74: 298–305.
17.
YarnykhVLBowenJDSamsonovA, et al. Fast whole-brain three-dimensional macromolecular proton fraction mapping in multiple sclerosis. Radiology2015; 274(1): 210–220.
18.
DortchRDLiKGochbergDF, et al. Quantitative magnetization transfer imaging of human brain at 3T via selective inversion recovery. Magn Reson Med2011; 66(5): 1346–1352.
19.
DortchRDMooreJLiK, et al. Quantitative magnetization transfer imaging of human brain at 7T. Neuroimage2013; 64: 640–649.
20.
BagnatoFHametnerSFrancoG, et al. Selective inversion recovery quantitative magnetization transfer brain MRI at 7T: clinical and post-mortem validation in multiple sclerosis. J Neuroimaging2018; 28(4): 380–388.
21.
SmithAKDortchRDDethrageLM, et al. Rapid, high-resolution quantitative magnetization transfer MRI of the human spinal cord. Neuroimage2014; 95: 106–116.
22.
DortchRDBagnatoFGochbergDF, et al. Optimization of selective inversion recovery magnetization transfer imaging for macromolecular content mapping in the human brain. Magn Reson Med2018; 80(5): 1824–1835.
23.
FazekasFRopeleSEnzingerC, et al. Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis. Mult Scler2002; 8(6): 479–484.
24.
LublinFDReingoldSCCohenJA, et al. Defining the clinical course of multiple sclerosis. Neurology2014; 83(3): 278–286.
25.
ThompsonAJBanwellBLBarkhofF, et al. Diagnosis of multiple sclerosis: 2017 revision of the McDonald criteria. Lancet Neurol2018; 17(2): 163–173.
26.
KurtzkeJF.Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology1983; 33(11): 1444–1452.
27.
CutterGRBaierMLRudickRA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain1999; 122(Pt 5): 871–882.
28.
FazekasFBarkhofFFilippiM.Unenhanced and enhanced magnetic resonance imaging in the diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiatry1998; 64(Suppl. 1): S2–S5.
29.
BagnatoFJeffriesNRichertND, et al. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for four years. Brain2003; 126(Pt8): 1782–1789.
30.
ZhangYYBradyMSmithS.Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging2001; 20(1): 45–57.
31.
CroninMJZhuJGochbergD, et al. Optimization and acceleration of selective inversion recovery imaging for practical whole-brain quantitative magnetization transfer measurements. In: ISMRM 2018, Paris, 16–21 June 2018, abstract 2229.
32.
BagnatoFHametnerSPennellD, et al. 7T MRI-histologic correlation study of low specific absorption rate T2-weighted GRASE sequences in the detection of white matter involvement in multiple sclerosis. J Neuroimaging2015; 25(3): 370–378.
33.
BagnatoFHametnerSBoydE, et al. Untangling the R2* contrast in multiple sclerosis: a combined MRI-histology study at 7.0 Tesla. PLoS ONE2018; 13(3): e0193839.
34.
AllenIVMcQuaidSMirakhurM, et al. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis. Neurol Sci2001; 22(2): 141–144.
35.
TrojanoMLiguoriGBosco ZimatoreG, et al. Age-related disability in multiple sclerosis. Ann Neurol2002; 51(4): 475–480.
